A Phase 2A, Open-Label Study Evaluating the Safety and Different Injection Techniques of CCH for the Treatment of Edematous Fibrosclerotic Panniculopathy (EFP)
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2019
Price : $35 *
At a glance
- Drugs Collagenase (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 05 Feb 2019 Status changed from active, no longer recruiting to completed.
- 26 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Sep 2018 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.